Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical Implications

Table 3

Number of patients and the percentage of FGF and CD68 expression within scores 0, 1, and 2 in examined groups (see legend for Table 2).

(a)

FGF expression	Control	Mild GO	Severe GO	Sum
≤10% no.	5	0	0	5
	71.43%	0.00%	0.00%
(10%; 50%) no.	2	6	7	15
	28.57%	75.00%	31.81%
>50% no.	0	2	15	17
	0.00%	25.00%	68.18%

(b)

CD68 expression	Control	Mild GO	Severe GO	Sum
≤10% no.	4	0	0	4
	57.14%	0.00%	0.00%
(10%; 50%) no.	3	4	7	14
	42.86%	50.00%	31.81%
>50% no.	0	4	15	19
	0.00%	50.00%	68.18%